Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
f. xu (Vancouver, Canada), N. Tanabe (Kyoto, Japan), J. Macdonough (Leuven, Belgium), D. Vasilescu (Vancouver, Canada), K. Ikezoe (VANCOUVER, Canada), D. Kinose (Shiga, Japan), K. Ng (London, United Kingdom), S. Verleden (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium), J. Verschakelen (Leuven, Belgium), J. Cooper ( ?Philadelphia, United States of America), M. Lenburg (Boston, United States of America), A. Spira (Boston, United States of America), R. Ng (VANCOUVER, Canada), J. Hogg (VANCOUVER, Canada). The transition from normal lung anatomy to Fibrosis in IPF. 470

Member's Comments

No comment yet.

Related content which might interest you: Difference in the dynamic state between SP-A and SP-D in the IPF lung Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014 Cystic fibrosis lung disease: from molecular defect to abnormal mucocilliary clearance Source: Annual Congress 2007 - PG4 - Paediatric respiratory medicine: cystic fibrosis – the basics Year: 2007 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Lung clearance index predicts pulmonary exacerbations in cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Comparison of physiological impairment in ILD patients with and without diagnostic IPF features Source: International Congress 2014 – ILDs 4 Year: 2014 Interstitial fibrosis with a nodule Source: Annual Congress 2007 - Thoracic Oncology Grand Round: an interactive session Year: 2007 Lung function measurements versus structural lung disease in CF Source: Breathe 2008; 5: 65 Year: 2008 Progression of early CT-detected structural lung damage in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections Year: 2010 Single-breath washout and association with structural lung changes in children with cystic fibrosis Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease Year: 2016 Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014 Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Analysis of pulmonary function in patients with idiopathic pulmonary fibrosis (IPF): how stable is stable IPF? Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Relations between the sinonasal development and the lung disease in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005